Colorado Capitol Watch
border Logo hdr_right_bottom

Bill Detail: HB18-1009

Return to list of bills


Title Diabetes Drug Pricing Transparency Act 2018
Status Senate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (05/02/2018)
Bill Subjects
  • Health Care & Health Insurance
House Sponsors D. Roberts (D)
Senate Sponsors K. Donovan (D)
House Committee Health, Insurance, & Environment
Senate Committee State, Veterans, and Military Affairs
Date Introduced 01/10/2018

The bill creates the Diabetes Drug Pricing Transparency Act of
2018. The state board of health is responsible for implementing the act.
Drug manufacturers and pharmacy benefit managers must submit annual
reports to the state board regarding drugs used to treat diabetes that are
subject to price increases of certain percentages. The state board analyzes
the submitted information and publishes a report. The state board may

impose penalties on drug manufacturers or pharmacy benefit managers
who ...

Committee Reports
with Amendments
Full Text
Full Text of Bill (most recent)
Fiscal Notes Fiscal Notes (08/15/2018) (most recent)  
Additional Bill Documents Bill Documents
  • Past bill versions
  • Past fiscal notes
  • Committee activity and documents
  • Bill History
Lobbyists Lobbyists
Votes House and Senate Votes
Vote Totals Vote Totals by Party
border   border
Copyright © 2018 State Capitol Watch